Source: Circulation. Unidade: FMRP
Assunto: CARDIOPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DILSIZIAN, V et al. Myocardial viability in patients with chronic coronary artery disease: comparison of 99 mtc-sestamibi with 201 thallium reinjection and [18f] fluorodeoxyglucose. Circulation, v. 89, n. 2 , p. 578-87, 1994Tradução . . Disponível em: https://doi.org/10.1161/01.cir.89.2.578. Acesso em: 08 jun. 2024.APA
Dilsizian, V., Arrighi, J. A., Diodati, J. G., Quyyumi, A. A., Alavi, K., Bacharach, S. L., et al. (1994). Myocardial viability in patients with chronic coronary artery disease: comparison of 99 mtc-sestamibi with 201 thallium reinjection and [18f] fluorodeoxyglucose. Circulation, 89( 2 ), 578-87. doi:10.1161/01.cir.89.2.578NLM
Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin Neto JA, Katsiyiannis PT, Bonow RO. Myocardial viability in patients with chronic coronary artery disease: comparison of 99 mtc-sestamibi with 201 thallium reinjection and [18f] fluorodeoxyglucose [Internet]. Circulation. 1994 ;89( 2 ): 578-87.[citado 2024 jun. 08 ] Available from: https://doi.org/10.1161/01.cir.89.2.578Vancouver
Dilsizian V, Arrighi JA, Diodati JG, Quyyumi AA, Alavi K, Bacharach SL, Marin Neto JA, Katsiyiannis PT, Bonow RO. Myocardial viability in patients with chronic coronary artery disease: comparison of 99 mtc-sestamibi with 201 thallium reinjection and [18f] fluorodeoxyglucose [Internet]. Circulation. 1994 ;89( 2 ): 578-87.[citado 2024 jun. 08 ] Available from: https://doi.org/10.1161/01.cir.89.2.578
